For example, the mutations in CTNNB1 occurred at a relatively high frequency in HCC, with a high expression of the protein kinase human monopolar spindle 1 (hMps1/TTK), and TTK inhibitors regarded as one of the potential targeted drugs for CTNNB1 mutant HCC28–30. This evidence concerns the gene TTK and hepatocellular carcinoma.